Get the Stockscreener App
8.25
2.25%
-0.19
After Hours:
8.21
-0.04
-0.48%
Kura Oncology Inc stock is traded at $8.25, with a volume of 2.18M.
It is down -2.25% in the last 24 hours and up +14.74% over the past month.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.
See More
Previous Close:
$8.44
Open:
$8.64
24h Volume:
2.18M
Relative Volume:
1.37
Market Cap:
$716.08M
Revenue:
-
Net Income/Loss:
$-168.09M
P/E Ratio:
-3.8018
EPS:
-2.17
Net Cash Flow:
$-138.01M
1W Performance:
+0.73%
1M Performance:
+14.74%
6M Performance:
+13.48%
1Y Performance:
-60.86%
1-Day Range:
$8.16
$8.75
1-Week Range:
$8.08
$8.75
52-Week Range:
$5.41
$21.40
Kura Oncology Inc Stock (KURA) Company Profile
Name
Kura Oncology Inc
Sector
Industry
Phone
(858) 500-8800
Address
12730 HIGH BLUFF DRIVE, SUITE 400, SAN DIEGO, CA
Compare KURA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KURA
Kura Oncology Inc
|
8.25 | 732.57M | 0 | -168.09M | -138.01M | -2.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.12 | 99.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
591.99 | 63.46B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.56 | 59.27B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
736.76 | 44.78B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
334.40 | 37.75B | 3.81B | -644.79M | -669.77M | -6.24 |
Kura Oncology Inc Stock (KURA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-04-25 | Initiated | Guggenheim | Neutral |
| Feb-06-25 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-24-24 | Initiated | UBS | Buy |
| Oct-14-24 | Downgrade | Stifel | Buy → Hold |
| Dec-22-23 | Initiated | Mizuho | Buy |
| Aug-11-23 | Initiated | BofA Securities | Buy |
| Jul-27-23 | Initiated | Scotiabank | Sector Perform |
| May-17-23 | Initiated | BTIG Research | Buy |
| Jan-31-23 | Initiated | Stifel | Buy |
| Jul-12-22 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-15-22 | Initiated | Jefferies | Buy |
| May-05-21 | Resumed | Credit Suisse | Outperform |
| Apr-26-21 | Resumed | Credit Suisse | Outperform |
| Dec-07-20 | Reiterated | H.C. Wainwright | Buy |
| Dec-03-20 | Initiated | Stifel | Buy |
| Nov-05-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-07-20 | Initiated | Credit Suisse | Outperform |
| May-05-20 | Initiated | Barclays | Overweight |
| Jul-18-19 | Initiated | Deutsche Bank | Buy |
| Nov-09-18 | Initiated | Piper Jaffray | Overweight |
| Aug-01-18 | Initiated | H.C. Wainwright | Buy |
| Oct-13-16 | Resumed | Leerink Partners | Outperform |
| Jan-22-16 | Initiated | JMP Securities | Mkt Outperform |
| Dec-30-15 | Initiated | Oppenheimer | Outperform |
| Dec-16-15 | Initiated | Citigroup | Buy |
View All
Kura Oncology Inc Stock (KURA) Latest News
330,421 Shares in Kura Oncology, Inc. $KURA Bought by Acadian Asset Management LLC - MarketBeat
Automated trading signals detected on Kura Oncology Inc.Weekly Gains Report & Risk Controlled Stock Pick Alerts - newser.com
Chart based exit strategy for Kura Oncology Inc.Weekly Trade Report & Low Drawdown Momentum Ideas - newser.com
Kura Oncology, Inc. $KURA Shares Sold by Goldman Sachs Group Inc. - MarketBeat
Is Kura Oncology Inc. still worth holding after the dipQuarterly Profit Report & Weekly Watchlist for Consistent Profits - newser.com
Kura Oncology Inc. stock prediction for this weekWeekly Stock Recap & Weekly Return Optimization Alerts - newser.com
Kura Oncology Transitioning To Commercial Stage: Why I Choose To Buy (NASDAQ:KURA) - Seeking Alpha
AQR Capital Management LLC Acquires 610,604 Shares of Kura Oncology, Inc. $KURA - MarketBeat
Will Kura Oncology Inc. bounce back from current supportQuarterly Market Review & Verified Technical Trade Signals - newser.com
What MACD signals say about Kura Oncology Inc.July 2025 PostEarnings & Weekly Watchlist for Hot Stocks - newser.com
Sentiment Watch: Can Kura Oncology Inc. disrupt its industryQuarterly Investment Review & Safe Investment Capital Preservation Plans - خودرو بانک
Historical volatility pattern of Kura Oncology Inc. visualized2025 Trade Ideas & Fast Entry Momentum Trade Alerts - newser.com
Will Kura Oncology Inc. price bounce be sustainableOptions Play & Advanced Swing Trade Entry Plans - newser.com
Aug Catalysts: Will Kura Oncology Inc. benefit from current market trendsWeekly Trend Report & Free Safe Capital Growth Stock Tips - khodrobank.com
Smart tools for monitoring Kura Oncology Inc.’s price actionJuly 2025 Summary & High Yield Equity Trading Tips - newser.com
Promising Developments in Kura Oncology’s FTI Programs Highlighted by Analyst Buy Rating - TipRanks
Intraday pattern recognizer results for Kura Oncology Inc.2025 Performance Recap & Real-Time Volume Analysis - newser.com
Is Kura Oncology Inc. stock reversal real or fake2025 Institutional Moves & Verified Swing Trading Watchlists - newser.com
Setup Watch: Can Kura Oncology Inc disrupt its industryJuly 2025 EndofMonth & Low Drawdown Investment Ideas - khodrobank.com
Death Cross: How liquid is FTAI Infrastructure Inc stockMarket Activity Summary & Low Risk Entry Point Guides - خودرو بانک
Analysis Recap: Is Kura Oncology Inc benefiting from innovation trendsJuly 2025 Price Swings & Accurate Entry/Exit Alerts - khodrobank.com
Kura Oncology to present preliminary data on cancer drug darlifarnib - Investing.com India
Kura Oncology (NASDAQ:KURA) Shares Down 4.1%Should You Sell? - MarketBeat
Applying chart zones and confluence areas to Kura Oncology Inc.2025 Top Gainers & Weekly High Return Stock Forecasts - newser.com
Kura Oncology Highlights Preclinical Data Demonstrating Potential of Farnesyl Transferase Inhibitors to Overcome Drug Resistance in Combination with Key Targeted Therapies Across Multiple Tumor Types - The Manila Times
Breakthrough Cancer Drug Resistance Solution: Kura's KO-2806 Shows Promise Across 200K+ US Patients - Stock Titan
AI Stocks: Whats the profit margin of Kura Oncology IncMarket Rally & AI Driven Stock Movement Reports - khodrobank.com
Valuation Update: Is Kura Oncology Inc. in a long term uptrendJuly 2025 Sentiment & Reliable Breakout Stock Forecasts - khodrobank.com
Jobs Data: Does Kura Oncology Inc. align with a passive investing strategyJuly 2025 Reactions & Long-Term Safe Investment Plans - khodrobank.com
Kura Oncology (NASDAQ:KURA) Shares Gap Up on Insider Buying Activity - MarketBeat
Kura Oncology (NASDAQ:KURA) CEO Troy Edward Wilson Buys 50,000 Shares - MarketBeat
Jacobs Levy Equity Management Inc. Boosts Holdings in Kura Oncology, Inc. $KURA - MarketBeat
Analysts Set Kura Oncology, Inc. (NASDAQ:KURA) PT at $24.10 - MarketBeat
Hedge Fund and Insider Trading News: Leon Cooperman, David Tepper, Warren Buffett, Citadel Investment Group, Elliott Investment Management, Kura Oncology Inc (KURA), Grindr Inc (GRND), and More - Insider Monkey
Biotech Stocks Rally After-Hours On Trial Updates, Insider Buys, And Conference Buzz - RTTNews
Ieq Capital LLC Buys New Shares in Kura Oncology, Inc. $KURA - MarketBeat
EcoR1 Capital LLC Reduces Position in Kura Oncology, Inc. $KURA - MarketBeat
Kura Oncology, Inc. $KURA Shares Bought by Graham Capital Management L.P. - MarketBeat
Kura Oncology at H.C. Wainwright: Strategic Pipeline Developments By Investing.com - Investing.com Canada
Kura Oncology Inc. Shows Early Signs of Technical StrengthWatch List & Fast Gain Stock Tips - beatles.ru
LifeSci Capital Maintains Buy Rating on Kura Oncology (KURA) - Insider Monkey
RA Capital Management L.P. Cuts Position in Kura Oncology, Inc. $KURA - MarketBeat
Kura Oncology Inc Stock (KURA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.43%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):